These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20595276)

  • 21. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population.
    Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP
    J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis.
    Manetti M; Allanore Y; Revillod L; Fatini C; Guiducci S; Cuomo G; Bonino C; Riccieri V; Bazzichi L; Liakouli V; Cipriani P; Giacomelli R; Abbate R; Bombardieri S; Valesini G; Montecucco C; Valentini G; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Rheum; 2011 Jan; 63(1):247-56. PubMed ID: 20967855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
    Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP
    J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
    Aulisa L; Papaleo P; Pola E; Angelini F; Aulisa AG; Tamburrelli FC; Pola P; Logroscino CA
    Spine (Phila Pa 1976); 2007 Nov; 32(24):2700-2. PubMed ID: 18007247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
    J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis.
    Assassi S; Mayes MD; McNearney T; Fischbach M; Reveille JD; Arnett FC; Tan FK
    Am J Med; 2005 Aug; 118(8):907-11. PubMed ID: 16084185
    [No Abstract]   [Full Text] [Related]  

  • 29. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
    Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
    Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis.
    Lee YH; Kim HJ; Rho YH; Choi SJ; Ji JD; Song GG
    Scand J Rheumatol; 2003; 32(4):235-9. PubMed ID: 14626631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease].
    Shevchenko AV; Golovanova OV; Konenkov VI; Tolkacheva OM; Maksimov VN; Voevoda MI; Romashchenko AG
    Ter Arkh; 2010; 82(1):31-4. PubMed ID: 20364697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the matrix metalloproteinase-3 (MMP-3) promoter polymorphism with celiac disease in male subjects.
    Mora B; Bonamico M; Ferri M; Megiorni F; Osborn J; Pizzuti A; Mazzilli MC
    Hum Immunol; 2005 Jun; 66(6):716-20. PubMed ID: 15993717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
    J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.
    Bossini-Castillo L; Broen JC; Simeon CP; Beretta L; Vonk MC; Ortego-Centeno N; Espinosa G; Carreira P; Camps MT; Navarrete N; González-Escribano MF; Vicente-Rabaneda E; Rodríguez L; Tolosa C; Román-Ivorra JA; Gómez-Gracia I; García-Hernández FJ; Castellví I; Gallego M; Fernández-Nebro A; García-Portales R; Egurbide MV; Fonollosa V; de la Peña PG; Pros A; González-Gay MA; Hesselstrand R; Riemekasten G; Witte T; Coenen MJ; Koeleman BP; Houssiau F; Smith V; de Keyser F; Westhovens R; De Langhe E; Voskuyl AE; Schuerwegh AJ; Chee MM; Madhok R; Shiels P; Fonseca C; Denton C; Claes K; Padykov L; Nordin A; Palm O; Lie BA; Airó P; Scorza R; van Laar JM; Hunzelmann N; Kreuter A; Herrick A; Worthington J; Radstake TR; Martín J; Rueda B
    Ann Rheum Dis; 2011 Apr; 70(4):638-41. PubMed ID: 21187296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
    Asano Y; Ihn H; Kubo M; Jinnin M; Mimura Y; Ashida R; Tamaki K
    Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase-2 promoter variability in psoriasis.
    Vasku V; Bienertova Vasku J; Slonková V; Kanková K; Vasku A
    Arch Dermatol Res; 2009 Jul; 301(6):467-73. PubMed ID: 19360430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population.
    Hollá LI; Jurajda M; Fassmann A; Dvorakova N; Znojil V; Vacha J
    J Clin Periodontol; 2004 Aug; 31(8):685-90. PubMed ID: 15257748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.